MNA
REGN icon

Manning & Napier Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Manning & Napier Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$127M Sell
284,193
-14,585
-5% -$6.94M 1.09% 34
2017
Q2 		$147M Sell
298,778
-77,225
-21% -$33.8M 1.26% 27
2017
Q1 		$146M Sell
376,003
-64,313
-15% -$23.8M 1.13% 38
2016
Q4 		$162M Buy
+440,316
New +$167M 1.06% 37

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Manning & Napier Advisors's REGN Position: Q3 2017 in Review

Manning & Napier Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 4.9% in Q3 2017, selling an estimated $6.94M and leaving 284,193 shares worth $127M. The position accounts for 1.09% of the portfolio, ranked #34.

Manning & Napier Advisors first reported a position in REGN in Q4 2016 and has held it in 4 quarters since. The position peaked at $162M in Q4 2016. 605 funds tracked by Wall St. Rank hold REGN as of Q3 2017.

  • Manning & Napier Advisors held 284,193 shares of Regeneron Pharmaceuticals worth $127M as of Q3 2017.
  • Manning & Napier Advisors sold 14,585 Regeneron Pharmaceuticals shares in Q3 2017, an estimated $6.94M.
  • Regeneron Pharmaceuticals made up 1.09% of Manning & Napier Advisors's portfolio in Q3 2017, its #34 holding.
  • Manning & Napier Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2016 and has held it in 4 quarters since.
  • Manning & Napier Advisors's Regeneron Pharmaceuticals position peaked at $162M in Q4 2016.
  • 605 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2017.

Based on Manning & Napier Advisors's 13F filing for Q3 2017, filed 7 Nov 2017.